EAS Congress
@EASCongress
Followers
4K
Following
4K
Media
2K
Statuses
6K
EAS is advancing & exchanging knowledge concerning the causes, natural history, treatment & prevention of atherosclerotic disease. #EASCongress2025
Glasgow, UK
Joined December 2010
Thank you for being part of #EASCongress2025!🌟.Over the last four days, we’ve shared groundbreaking discoveries, bold ideas & a passion for advancing #atherosclerosis research & care. Let’s keep the momentum going - the future of #cardiovascular health starts with all of us! 🫀
0
1
10
RT @society_eas: 🎙️ New AtheroTalk episode out now!. In this special live episode recorded at the #EASCongress2025, hosts Emiel Van der Vor….
0
2
0
RT @FedericaFogacci: #MyEAS2025 The live discussion of my case on statin intolerance at #EASCongress2025 was truly exciting! The EAS Stage….
0
4
0
RT @SoheilSaeedi5: A great week at @EASCongress in Glasgow🏴!.💡Glad to present our discovery on gut #microbiota & #atherosclerosis. 💡P….
0
6
0
RT @OTerenghi: Just got home from my 4th @EASCongress in #Glasgow! 🏴🇬🇧.A great chance to learn and share science 🔬🩺🧬.Looking forward….
0
2
0
RT @Danila_Gurgone: What a whirlwind! After coordinating the @britathsoc summer school and having the honour to present at #EASCongress202….
0
2
0
RT @atherosociety: What an insightful joint session at #EASCongress2025! IAS and @society_eas collaborated on a joint session moderated by….
0
5
0
RT @FedericaFogacci: 💡 Key takeaway in one line! #EASCongress2025 #MyEAS2025.Excited to share the latest breakthroughs in lipid research an….
0
6
0
RT @pabeda1: Short thread: #1: A few personal highlights of this amazing #EASCongress2025 @PamTaubMD, Belga Skuladottir, Alberto Zambon, @….
0
3
0
RT @icorvilud: New European Atherosclerosis Society consensus statement.✍️Clinical staging to guide management of metabolic disorders/seque….
0
12
0
RT @MariaGi31609461: Very 💥 💥💥 data presented by Chiara Macchi at #EASCongress2025!! In #ApoE KO mouse model, she showed that #BempedoicAci….
0
4
0
RT @MariaGi31609461: Great Poster Presentation by Giorgia Marodin form our Lab at #EASCongress2025 in #Glasgow! She discussed her latest fi….
0
3
0
RT @azinkh96: 🔈Excellent presentations are being delivered at the Workshop on Inflammatory Mechanisms in Atherosclerosis!.#EASCongress2025….
0
4
0
RT @MaximaMendez15: Professor Steven Niessen during his presentation at @EASCongress . #LateBreakingTrials #EASCongress2025 . @society_eas….
0
3
0
RT @MeralKayikcoglu: An outstanding presentation & an excellent new guideline!.The latest @easociety Consensus Statement is a must-read:.“C….
0
13
0
RT @tmodarressi: Impressive data regarding the effectiveness of $NAMS obicetrapib-ezetimibe combo — 71% get to LDL <55 mg/dL. Lp(a) mean re….
0
4
0
RT @MaximaMendez15: More of the late breaking clinical trials presentations at #EASCongress2025 this time by Professor @BNordestgaard . @….
0
2
0
RT @FedericaFogacci: Exciting new European Atherosclerosis Society Consensus Statement on clinical staging to guide actionable management o….
0
6
0
RT @tmodarressi: “Staging” of cardiometabolic disease continues to expand and evolve, as w @American_Heart CKM Syndrome and now the @societ….
0
9
0
RT @FedericaFogacci: The first human experience with MAR001, a drug targeting ANGPTL4, shows promising results. Phase 2a demonstrated a 50%….
0
5
0
RT @tmodarressi: ANGPTL4 mAb with seemingly robust impacts in TG and remnant cholesterol, accentuated impact in those with TG>200. Presente….
0
5
0